133 related articles for article (PubMed ID: 31466835)
21. Base promoted synthesis of novel indole-dithiocarbamate compounds as potential anti-inflammatory therapeutic agents for treatment of acute lung injury.
Song Z; Zhou Y; Zhang W; Zhan L; Yu Y; Chen Y; Jia W; Liu Z; Qian J; Zhang Y; Li C; Liang G
Eur J Med Chem; 2019 Jun; 171():54-65. PubMed ID: 30909020
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of novel 2-sulfonylindoles as potential anti-inflammatory therapeutic agents for treatment of acute lung injury.
Xia Q; Bao X; Sun C; Wu D; Rong X; Liu Z; Gu Y; Zhou J; Liang G
Eur J Med Chem; 2018 Dec; 160():120-132. PubMed ID: 30326372
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
[TBL] [Abstract][Full Text] [Related]
24. Flavokawain B alleviates LPS-induced acute lung injury via targeting myeloid differentiation factor 2.
Luo W; Yang LB; Qian CC; Ma B; Manjengwa GM; Miao XM; Wang J; Hu CH; Jin B; Zhang LX; Zheng C; Liang G; Wang Y
Acta Pharmacol Sin; 2022 Jul; 43(7):1758-1768. PubMed ID: 34737421
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and structure-activity relationship studies of 4-indole-2-arylaminopyrimidine derivatives as anti-inflammatory agents for acute lung injury.
Chen T; Wei Y; Zhu G; Zhao H; Zhang X
Eur J Med Chem; 2021 Dec; 225():113766. PubMed ID: 34425313
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effect and mechanism study of L-cysteine derivative 5P39 on LPS-induced acute lung injury in mice.
He Y; Zhao Y; Feng Y; Ren A; Zhang Y; Wang Y; Li H
Eur J Pharmacol; 2020 Feb; 869():172893. PubMed ID: 31883915
[TBL] [Abstract][Full Text] [Related]
27. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice.
Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y
Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864
[TBL] [Abstract][Full Text] [Related]
28. Cardamonin inhibits LPS-induced inflammatory responses and prevents acute lung injury by targeting myeloid differentiation factor 2.
Yang L; Luo W; Zhang Q; Hong S; Wang Y; Samorodov AV; Chattipakorn N; Pavlov VN; Liang G
Phytomedicine; 2021 Dec; 93():153785. PubMed ID: 34638032
[TBL] [Abstract][Full Text] [Related]
29. SU5416 attenuated lipopolysaccharide-induced acute lung injury in mice by modulating properties of vascular endothelial cells.
Huang X; Zhu J; Jiang Y; Xu C; Lv Q; Yu D; Shi K; Ruan Z; Wang Y
Drug Des Devel Ther; 2019; 13():1763-1772. PubMed ID: 31213766
[No Abstract] [Full Text] [Related]
30. Protective effect of resveratrol against acute lung injury induced by lipopolysaccharide via inhibiting the myd88-dependent Toll-like receptor 4 signaling pathway.
Zhang Z; Chen N; Liu JB; Wu JB; Zhang J; Zhang Y; Jiang X
Mol Med Rep; 2014 Jul; 10(1):101-6. PubMed ID: 24818579
[TBL] [Abstract][Full Text] [Related]
31. Sulforaphane inhibits the engagement of LPS with TLR4/MD2 complex by preferential binding to Cys133 in MD2.
Koo JE; Park ZY; Kim ND; Lee JY
Biochem Biophys Res Commun; 2013 May; 434(3):600-5. PubMed ID: 23583403
[TBL] [Abstract][Full Text] [Related]
32. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways.
Liu YL; Liu YJ; Liu Y; Li XS; Liu SH; Pan YG; Zhang J; Liu Q; Hao YY
Int Immunopharmacol; 2014 Dec; 23(2):649-57. PubMed ID: 25466274
[TBL] [Abstract][Full Text] [Related]
33. The antimicrobial peptide LK2(6)A(L) exhibits anti-inflammatory activity by binding to the myeloid differentiation 2 domain and protects against LPS-induced acute lung injury in mice.
Zhang J; Sun Y; Sun C; Shang D
Bioorg Chem; 2023 Mar; 132():106376. PubMed ID: 36706531
[TBL] [Abstract][Full Text] [Related]
34. Hesperetin ameliorates lipopolysaccharide-induced acute lung injury in mice through regulating the TLR4-MyD88-NF-κB signaling pathway.
Wang N; Geng C; Sun H; Wang X; Li F; Liu X
Arch Pharm Res; 2019 Dec; 42(12):1063-1070. PubMed ID: 31802426
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and bioactivity evaluation of fisetin derivatives as potential anti-inflammatory agents against LPS-induced acute lung injury.
Wang X; Yang J; Ding B; Chen P; Xu Z; Zhao Y; Chen P; Chattipakorn N; Liang G; Wu D; Tang Q
Bioorg Med Chem; 2021 Nov; 49():116456. PubMed ID: 34628233
[TBL] [Abstract][Full Text] [Related]
36. Artemisinin inhibits TLR4 signaling by targeting co-receptor MD2 in microglial BV-2 cells and prevents lipopolysaccharide-induced blood-brain barrier leakage in mice.
Zhang T; Zhang X; Lin C; Wu S; Wang F; Wang H; Wang Y; Peng Y; Hutchinson MR; Li H; Wang X
J Neurochem; 2021 May; 157(3):611-623. PubMed ID: 33453127
[TBL] [Abstract][Full Text] [Related]
37. Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for inflammatory diseases.
Chen L; Fu W; Zheng L; Wang Y; Liang G
Drug Discov Today; 2018 Jun; 23(6):1187-1202. PubMed ID: 29330126
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and Anti-Inflammatory Evaluation of Novel C66 Analogs for the Treatment of LPS-Induced Acute Lung Injury.
Feng J; Xiao B; Chen W; Ding T; Chen L; Yu P; Xu F; Zhang H; Liu Z; Liang G
Chem Biol Drug Des; 2015 Oct; 86(4):753-63. PubMed ID: 25727339
[TBL] [Abstract][Full Text] [Related]
39. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and bioactivity evaluation of 4-hydroxycoumarin derivatives as potential anti-inflammatory agents against acute lung injury and colitis.
Li X; Huang X; Zhao Y; Zheng Z; Guo M; Chen Z; Chen P; Li X; Liao J; Jiang M; Cho WJ; Cho YC; Zeng R; Tang Q; Liang G
Eur J Med Chem; 2024 Jun; 272():116487. PubMed ID: 38759452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
